Ka O. Lam
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Cross-Platform Gene Signature to Predict Survival Outcomes for Nasopharyngeal Carcinoma.
Journal: JCO precision oncology
Published: July 01, 2026
A novel STAT4 gain-of-function variant defines a monogenic form of juvenile-onset systemic lupus erythematosus.
Journal: Annals of the rheumatic diseases
Published: February 21, 2026
Switching Cancer-associated Venous Thromboembolism Treatment from Continuous LMWH to DOACs: An Evaluation.
Journal: Thrombosis and haemostasis
Published: January 30, 2026
Safety and Effectiveness of Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparin for Cancer-Associated Thrombosis: A Systematic Review and Meta-analysis.
Journal: Drug safety
Published: October 28, 2025
A remarkable journey: the development of radiographer training in Hong Kong.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: April 23, 2025
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion study.
Journal: Cancer
Published: August 23, 2024
Direct oral anticoagulants versus low-molecular-weight heparin in patients with cancer-associated venous thrombosis: a cost-effectiveness analysis.
Journal: Journal of pharmaceutical policy and practice
Published: July 19, 2024
ImmuneMirror for evaluation of the genomic and transcriptomic features of resistance to immunotherapy for gastrointestinal tract cancer: abridged secondary publication.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: July 04, 2024
Radiosensitivity index as a predictive biomarker for radiotherapy de-intensification in nasopharyngeal carcinoma: abridged secondary publication.
Journal: Hong Kong medical journal = Xianggang yi xue za zhi
Published: February 27, 2024
Using the genomic adjusted radiation dose (GARD) to personalize the radiation dose in nasopharyngeal cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: December 15, 2023
Shift in Tissue-Specific Immune Niches and CD137 Expression in Tuberculoma of Pembrolizumab-Treated Nasopharyngeal Carcinoma Patients.
Journal: Cancers
Published: December 07, 2023
Last Updated: 09/26/2026